CN103393710A - 一种发酵虫草菌粉多糖复合物的制备方法及用途 - Google Patents
一种发酵虫草菌粉多糖复合物的制备方法及用途 Download PDFInfo
- Publication number
- CN103393710A CN103393710A CN201310319840XA CN201310319840A CN103393710A CN 103393710 A CN103393710 A CN 103393710A CN 201310319840X A CN201310319840X A CN 201310319840XA CN 201310319840 A CN201310319840 A CN 201310319840A CN 103393710 A CN103393710 A CN 103393710A
- Authority
- CN
- China
- Prior art keywords
- polysaccharide
- cordyceps
- intracellular
- extracellular
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 196
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 196
- 150000004676 glycans Chemical class 0.000 title claims abstract description 135
- 239000000843 powder Substances 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 241001248610 Ophiocordyceps sinensis Species 0.000 title claims abstract description 10
- 241000190633 Cordyceps Species 0.000 claims abstract description 71
- 230000003834 intracellular effect Effects 0.000 claims abstract description 42
- 238000000855 fermentation Methods 0.000 claims abstract description 11
- 230000004151 fermentation Effects 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 238000000605 extraction Methods 0.000 claims abstract description 8
- -1 polysaccharides compound Chemical class 0.000 claims description 68
- 239000007788 liquid Substances 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 21
- 239000006228 supernatant Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000007924 injection Substances 0.000 claims description 12
- 238000002347 injection Methods 0.000 claims description 12
- 239000000741 silica gel Substances 0.000 claims description 12
- 229910002027 silica gel Inorganic materials 0.000 claims description 12
- 238000001556 precipitation Methods 0.000 claims description 10
- 239000012153 distilled water Substances 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 150000004804 polysaccharides Polymers 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 238000005238 degreasing Methods 0.000 claims description 2
- 230000003544 deproteinization Effects 0.000 claims description 2
- 239000000385 dialysis solution Substances 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 210000004243 sweat Anatomy 0.000 claims description 2
- 239000006189 buccal tablet Substances 0.000 claims 1
- 229940046011 buccal tablet Drugs 0.000 claims 1
- 229940068682 chewable tablet Drugs 0.000 claims 1
- 239000007910 chewable tablet Substances 0.000 claims 1
- 239000007919 dispersible tablet Substances 0.000 claims 1
- 230000036039 immunity Effects 0.000 abstract description 9
- 230000006870 function Effects 0.000 abstract description 4
- 230000007969 cellular immunity Effects 0.000 abstract description 2
- 230000004727 humoral immunity Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 22
- 241000699666 Mus <mouse, genus> Species 0.000 description 20
- 238000012360 testing method Methods 0.000 description 19
- 239000006285 cell suspension Substances 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 12
- 210000002966 serum Anatomy 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 210000003024 peritoneal macrophage Anatomy 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 230000003203 everyday effect Effects 0.000 description 10
- 230000000242 pagocytic effect Effects 0.000 description 10
- 239000003814 drug Substances 0.000 description 8
- 206010061598 Immunodeficiency Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 210000003743 erythrocyte Anatomy 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000003304 gavage Methods 0.000 description 7
- 230000009471 action Effects 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 238000001802 infusion Methods 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 5
- 241000287828 Gallus gallus Species 0.000 description 5
- 108010006464 Hemolysin Proteins Proteins 0.000 description 5
- 239000012980 RPMI-1640 medium Substances 0.000 description 5
- 239000012531 culture fluid Substances 0.000 description 5
- 229960004397 cyclophosphamide Drugs 0.000 description 5
- 239000003228 hemolysin Substances 0.000 description 5
- 210000002540 macrophage Anatomy 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 239000000470 constituent Substances 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 3
- 102000015696 Interleukins Human genes 0.000 description 3
- 108010063738 Interleukins Proteins 0.000 description 3
- 241001529936 Murinae Species 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 208000033065 inborn errors of immunity Diseases 0.000 description 3
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000007306 turnover Effects 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000000976 ink Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 210000005087 mononuclear cell Anatomy 0.000 description 2
- 210000004279 orbit Anatomy 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N 2-propanol Substances CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- 206010014025 Ear swelling Diseases 0.000 description 1
- 206010015719 Exsanguination Diseases 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229960001008 heparin sodium Drugs 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310319840.XA CN103393710B (zh) | 2013-07-26 | 2013-07-26 | 一种发酵虫草菌粉多糖复合物的制备方法及用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310319840.XA CN103393710B (zh) | 2013-07-26 | 2013-07-26 | 一种发酵虫草菌粉多糖复合物的制备方法及用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103393710A true CN103393710A (zh) | 2013-11-20 |
CN103393710B CN103393710B (zh) | 2015-09-02 |
Family
ID=49557565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310319840.XA Active CN103393710B (zh) | 2013-07-26 | 2013-07-26 | 一种发酵虫草菌粉多糖复合物的制备方法及用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103393710B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105055577A (zh) * | 2015-09-06 | 2015-11-18 | 青海之也科技咨询服务有限公司 | 一种冬虫夏草保健片及其制备方法 |
CN105878188A (zh) * | 2014-11-06 | 2016-08-24 | 王辉 | 一种发酵冬虫夏草胞外多糖颗粒剂及其制备方法 |
CN106912953A (zh) * | 2017-01-22 | 2017-07-04 | 楼良水 | 虫草多糖复合物及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101353382A (zh) * | 2008-09-11 | 2009-01-28 | 浙江工业大学 | 一种抗氧化活性虫草多糖的提取方法 |
CN101560268A (zh) * | 2009-05-31 | 2009-10-21 | 江西济民可信集团有限公司 | 一种Cs-4发酵菌丝体多糖及其制备方法与用途 |
CN102618598A (zh) * | 2012-04-16 | 2012-08-01 | 山东省农业科学院农业资源与环境研究所 | 一种利用扩张蛋白提高虫草多糖产量的液体发酵方法 |
-
2013
- 2013-07-26 CN CN201310319840.XA patent/CN103393710B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101353382A (zh) * | 2008-09-11 | 2009-01-28 | 浙江工业大学 | 一种抗氧化活性虫草多糖的提取方法 |
CN101560268A (zh) * | 2009-05-31 | 2009-10-21 | 江西济民可信集团有限公司 | 一种Cs-4发酵菌丝体多糖及其制备方法与用途 |
CN102618598A (zh) * | 2012-04-16 | 2012-08-01 | 山东省农业科学院农业资源与环境研究所 | 一种利用扩张蛋白提高虫草多糖产量的液体发酵方法 |
Non-Patent Citations (1)
Title |
---|
张建军 等: "虫草多糖结构及免疫功能研究进展", 《安徽农业科学》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105878188A (zh) * | 2014-11-06 | 2016-08-24 | 王辉 | 一种发酵冬虫夏草胞外多糖颗粒剂及其制备方法 |
CN105055577A (zh) * | 2015-09-06 | 2015-11-18 | 青海之也科技咨询服务有限公司 | 一种冬虫夏草保健片及其制备方法 |
CN106912953A (zh) * | 2017-01-22 | 2017-07-04 | 楼良水 | 虫草多糖复合物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103393710B (zh) | 2015-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9662349B2 (en) | Dietary composition having mixed polysaccharides derived from lucid ganoderma, lycium barbarum and polygonatum sibiricum and method of its preparation | |
CN101856120A (zh) | 一种提高人体免疫力的保健食品及其制备方法 | |
CN102242044A (zh) | 一种蝉花酒及其制备 | |
CN105434842A (zh) | 一种增强免疫力、改善睡眠的中药组合物及其制剂和制法 | |
CN103301290A (zh) | 复方龙眼多糖免疫固本方剂及其制备方法 | |
CN103393710B (zh) | 一种发酵虫草菌粉多糖复合物的制备方法及用途 | |
CN104187678A (zh) | 一种降血脂的保健组合物及其生产方法 | |
CN102960715A (zh) | 一种具有提高免疫力、耐缺氧的保健食品及其制备方法 | |
CN104667197A (zh) | 一种增强免疫力的组合物及其制备方法和应用 | |
CN103627601B (zh) | 一种中草药保健酒及其制备方法 | |
CN100348212C (zh) | 一种用于调节免疫力的中药胶囊及其制备方法 | |
CN104352521B (zh) | 制备小牛脾提取物的方法及在抗肿瘤和免疫调节中的应用 | |
CN102754833B (zh) | 增强免疫力的保健品及其制备方法 | |
CN106924548A (zh) | 一种缓解疲劳的药物及制备方法 | |
CN107397765A (zh) | 一种破壁灵芝孢子提取物及其提取方法和应用 | |
CN107951992A (zh) | 一种用于增强免疫力的中药组合物及其制备方法 | |
CN104189038B (zh) | 用于调理女性生理健康和免疫功能的中药制剂 | |
CN106728387A (zh) | 一种具有促进免疫功能的复方药物及其制备方法 | |
CN107223966A (zh) | 一种用于提高免疫力的蓉草甘口服液及其制备方法 | |
CN106728703A (zh) | 一种抗疲劳、提高免疫力的复方中药口服液及其制备方法 | |
CN102973725A (zh) | 香菇多糖胶囊 | |
CN102406172B (zh) | 增强免疫力的保健食品及其制备方法 | |
CN102008563A (zh) | 一种抗癌中药及其配制方法 | |
CN107029101B (zh) | 一种提高免疫力的虫草佛手口服液 | |
CN101301075B (zh) | 一种含韭菜籽增强免疫力功能性食品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 330096 No. seven, No. 888, hi tech Zone, Nanchang hi tech Zone, Jiangxi Patentee after: Jiangxi Jinshuibao Pharmaceutical Co.,Ltd. Address before: 330096 No. seven, No. 888, hi tech Development Zone, Jiangxi, Nanchang Patentee before: JIANGXI JIMINKEXIN JINSHUIBAO PHARMACEUTICAL Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method and application of polysaccharide complex of Fermented Cordyceps sinensis powder Effective date of registration: 20211224 Granted publication date: 20150902 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: Jiangxi Jinshuibao Pharmaceutical Co.,Ltd. Registration number: Y2021980016165 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220902 Granted publication date: 20150902 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: Jiangxi Jinshuibao Pharmaceutical Co.,Ltd. Registration number: Y2021980016165 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A kind of preparation method and use of fermented Cordyceps fungus powder polysaccharide complex Effective date of registration: 20220905 Granted publication date: 20150902 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: Jiangxi Jinshuibao Pharmaceutical Co.,Ltd. Registration number: Y2022980014590 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230830 Granted publication date: 20150902 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: Jiangxi Jinshuibao Pharmaceutical Co.,Ltd. Registration number: Y2022980014590 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method and application of a fermented cordyceps fungus powder polysaccharide complex Effective date of registration: 20230831 Granted publication date: 20150902 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: Jiangxi Jinshuibao Pharmaceutical Co.,Ltd. Registration number: Y2023980054963 |